摘要 |
A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof: wherein one of R<SUP>1 </SUP>and R<SUP>2 </SUP>represents hydrogen atom and the other represents the formula -X-A wherein A represents hydrogen atom or an acyl group, X represents oxgen atom or NH; one of R<SUP>3 </SUP>and R<SUP>4 </SUP>represents hydrogen atom and the other represents the following formula: wherein Y represents a sulfonyl group or a carbonyl group, R<SUP>5 </SUP>represents a cyclic group, Z represents a single bond or a C<SUB>1 </SUB>to C<SUB>4 </SUB>alkylene group, R<SUP>6 </SUP>represents hydrogen atom or a C<SUB>1 </SUB>to C<SUB>6 </SUB>alkyl group.
|